Beteiligung an „Cells in Motion“
- Forschungsinteressen: immunology, induction and analysis of immune tolerance, molecular mechanisms of inflammatory skin diseases and skin cancer, contact hypersensitivity, therapeutic use of nanoparticlesf their individual elements; biology-inspired artificial hardware for information processing; materials for sustainably interfacing both classes of matter
- Mitglied im Graduiertenprogramm CiM-IMPRS
Publikationen im Forschungsschwerpunkt „Zelldynamik und Bildgebung“
2022
Fleischer MI, Rohrig N, Raker VK, Springer J, Becker D, Ritz S, Bros M, Stege H, Haist M, Grabbe S, Haub J, Becker C, Reyda S, Disse J, Schmidt T, Mahnke K, Weiler H, Ruf W, Steinbrink K. Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation. J Thromb Haemost 2022;20: 2823-2836. Abstract Kaczmarek-Szczepanska B, Pin JM, Zasada L, Sonne MM, Reiter RJ, Slominski AT, Steinbrink K, Kleszczynski K. Assessment of Melatonin-Cultured Collagen/Chitosan Scaffolds Cross-Linked by a Glyoxal Solution as Biomaterials for Wound Healing. Antioxidants (Basel) 2022;11Abstract Shahneh F, Christian Probst H, Wiesmann SC, A-Gonzalez N, Ruf W, Steinbrink K, Raker VK, Becker C. Inflammatory Monocyte Counts Determine Venous Blood Clot Formation and Resolution. Arterioscler Thromb Vasc Biol 2022;42: 145-155. Abstract Stegemann A, Raker V, Del Rey A, Steinbrink K, Bohm M. Expression of the alpha7 Nicotinic Acetylcholine Receptor Is Critically Required for the Antifibrotic Effect of PHA-543613 on Skin Fibrosis. Neuroendocrinology 2022;112: 446-456. Abstract